Third-party regulatory T cells prevent murine acute graft-versus-host disease

BACKGROUND/AIMS: Adoptive therapy with regulatory T (Treg) cells to prevent graft-versus-host disease (GVHD) would benefit from a strategy to improve homing to the sites of inflammation following hematopoietic stem cell transplantation (HSCT). Although donor-derived Treg cells have mainly been used...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Korean J Intern Med
Auteurs principaux: Lim, Jung-Yeon, Im, Keon-Il, Song, Yunejin, Kim, Nayoun, Nam, Young-Sun, Jeon, Young-Woo, Cho, Seok-Goo
Format: Artigo
Langue:Inglês
Publié: The Korean Association of Internal Medicine 2018
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6129628/
https://ncbi.nlm.nih.gov/pubmed/29050459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.319
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires